These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling. Yang F; Nam S; Brown CE; Zhao R; Starr R; Ma Y; Xie J; Horne DA; Malkas LH; Jove R; Hickey RJ PLoS One; 2014; 9(4):e94443. PubMed ID: 24732116 [TBL] [Abstract][Full Text] [Related]
12. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma. Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755 [TBL] [Abstract][Full Text] [Related]
13. Cardamonin induces apoptosis by suppressing STAT3 signaling pathway in glioblastoma stem cells. Wu N; Liu J; Zhao X; Yan Z; Jiang B; Wang L; Cao S; Shi D; Lin X Tumour Biol; 2015 Dec; 36(12):9667-76. PubMed ID: 26150336 [TBL] [Abstract][Full Text] [Related]
14. Bax Activation Blocks Self-Renewal and Induces Apoptosis of Human Glioblastoma Stem Cells. Daniele S; Pietrobono D; Costa B; Giustiniano M; La Pietra V; Giacomelli C; La Regina G; Silvestri R; Taliani S; Trincavelli ML; Da Settimo F; Novellino E; Martini C; Marinelli L ACS Chem Neurosci; 2018 Jan; 9(1):85-99. PubMed ID: 28368610 [TBL] [Abstract][Full Text] [Related]
15. Ovatodiolide inhibits the oncogenicity and cancer stem cell-like phenotype of glioblastoma cells, as well as potentiate the anticancer effect of temozolomide. Su YK; Bamodu OA; Tzeng YM; Hsiao M; Yeh CT; Lin CM Phytomedicine; 2019 Aug; 61():152840. PubMed ID: 31035045 [TBL] [Abstract][Full Text] [Related]
16. Targeted inhibition of dominant PI3-kinase catalytic isoforms increase expression of stem cell genes in glioblastoma cancer stem cell models. Jones NM; Rowe MR; Shepherd PR; McConnell MJ Int J Oncol; 2016 Jul; 49(1):207-16. PubMed ID: 27176780 [TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rh2 inhibits growth of glioblastoma multiforme through mTor. Li S; Guo W; Gao Y; Liu Y Tumour Biol; 2015 Apr; 36(4):2607-12. PubMed ID: 25431263 [TBL] [Abstract][Full Text] [Related]
18. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3. Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931 [TBL] [Abstract][Full Text] [Related]
19. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal. Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223 [TBL] [Abstract][Full Text] [Related]
20. The antiproliferative and apoptotic effects of apigenin on glioblastoma cells. Stump TA; Santee BN; Williams LP; Kunze RA; Heinze CE; Huseman ED; Gryka RJ; Simpson DS; Amos S J Pharm Pharmacol; 2017 Jul; 69(7):907-916. PubMed ID: 28349530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]